AMLN (DIABETES DRUGS) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AMLN (DIABETES DRUGS)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Cacaito who wrote (994)	12/4/1997 6:39:00 PM
From: D.Right	Read Replies (2) of 2173

Dear Cacaito: AMLN did a clinical II to mix pramlintide with insulin in syringes just before injection. The results were positive. The news release was on Jan. 8, 1997. You can find it from the company home page under investor relations. They are planing to do more trials on different ratios of this pramlintide-insulin mixing as stated in their last quarter report. These will be short duration trials (one month?), I believe. D.Right

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next